Walking the Thin Line: Compounding Ethics of Weight Loss Drugs addressed the rising notoriety of designer weight loss drugs like Ozempic have led to short supply. Are the alternatives of compounded GLP-1 weight loss drugs sold by med spas and others an affordable alternative or risky gamble? A panel moderated by Michael DiStefano, PhD, MBE, from Skaggs School of Pharmacy and Pharmaceutical Sciences, included Andrew Timothy Kraftson, MD, from University of Michigan Medical School and Gina D. Moore, PharmD, MBA, Senior Associate Dean for Operations and Regulatory Affairs at Skaggs School of Pharmacy and Pharmaceutical Sciences.  Presented on April 8, 2024.